Table 2.
Profile of patients at their first clinic visit during reporting period Q2 2018 – Q4 2019, Dakar
| Diagnosed | Treated | Controlled BP (at the last visit) | Among all patients with data | |||||
|---|---|---|---|---|---|---|---|---|
| Total N = 6056 | % | Total N = 5236 | % | Total N = 1016 | % | Treated Crude OR (95% CI) | BP controlled Crude OR (95% CI) | |
| Age (years) | ||||||||
| 18–29 | 110 | 1·8 | 84 | 1·6 | 9 | 0·9 | REF | REF |
| 30–44 | 797 | 13·2 | 652 | 12·5 | 115 | 11·3 | 1·4 (0·8, 2·3) | 1·9 (0·9, 4·4) |
| 45–59 | 2017 | 33·3 | 1753 | 33·5 | 333 | 32·8 | 2·1 (1·2, 3·3) ¥¥ | 2·2 (1·1, 5·0) ¥ |
| 60–69 | 1777 | 29·3 | 1584 | 30·3 | 334 | 32·9 | 2·5 (1·5, 4·1) ¥¥¥ | 2·6 (1·3, 5·9) ¥¥ |
| 70–79 | 840 | 13·9 | 743 | 14·2 | 159 | 15·6 | 2·4 (1·4, 3·9) ¥¥¥ | 2·6 (1·3, 6·0) ¥¥ |
| ≥ 80 | 227 | 3·7 | 184 | 3·5 | 32 | 3·1 | 1·3 (0·7, 2·4) | 1·8 (0·8, 4·6) |
| Missing age information | 288 | 4·8 | 236* | 4·5 | 34* | 3·3 | NA | NA |
| Sex | REF: MEN | REF: MEN | ||||||
| Women | 4669 | 77·1 | 4071 | 77·8 | 806 | 79·3 | 1·3 (1·1, 1·5) ¥¥ | 1·2 (0·9, 1·4) |
| Missing sex information | 0 | 0·0 | 0 | 0·0 | 0 | 0·0 | NA | NA |
| BP Categories (mmHg) | ||||||||
| < 120 and < 80 mmHg | 146 | 2·4 | 132 | 2·5 | 41 | 4·0 | REF | REF |
| 120–129 or 80–84 mmHg | 313 | 5·2 | 280 | 5·3 | 85 | 8·4 | 0·9 (0·4, 1·8) | 1·0 (0·6, 1·5) |
| 130–139 or 85–89 mmHg | 656 | 10·8 | 563 | 10·8 | 152 | 15·0 | 0·6 (0·3, 1·2) | 0·8 (0·5, 1·2) |
| 140–159 or 90–99 mmHg | 2207 | 36·4 | 1923 | 36·7 | 427 | 42·0 | 0·7 (0·4, 1·3) | 0·6 (0·4, 0·9) ¥ |
| 160–179 or 100–109 mmHg | 1527 | 25·2 | 1324 | 25·3 | 218 | 21·5 | 0·7 (0·4, 1·2) | 0·4 (0·3, 0·6) ¥¥¥ |
| ≥ 180 or ≥ 110 mmHg | 1112 | 18·4 | 986 | 18·8 | 90 | 8·9 | 0·8 (0·4, 1·5) | 0·2 (0·1, 0·4) ¥¥¥ |
| Missing BP information | 95 | 1·6 | 28*** | 0·5 | 3*** | 0·3 | NA | NA |
| CV Riska | ||||||||
| Low | 1119 | 18·5 | 1007 | 19·2 | 237 | 23·3 | REF | REF |
| Moderate/Intermediate | 1564 | 25·8 | 1436 | 27·4 | 282 | 27·8 | 1·2 (0·9, 1·6) | 0·8 (0·7, 1·0) ¥ |
| High | 2459 | 40·6 | 2295 | 43·8 | 385 | 37·9 | 1·6 (1·2, 2·0) ¥¥¥ | 0·7 (0·6, 0·8) ¥¥¥ |
| Missing | 914 | 15·1 | 498*** | 9·5 | 112*** | 11·0 | NA | NA |
Chi-square test for statistical significance for missingness of patient characteristic data *p < 0·05, **p < 0·01, ***p < 0·001
BP blood pressure, CI confidence intervals, CV cardiovascular, NA not applicable, OR odds ratio, REF reference
aCV risk was defined according to city-specific guidelines (see S3)
Crude odds ratios and 95% CIs estimated only among patients with non-missing data and rounded to one decimal place; ¥p < 0·05, ¥¥p < 0·01, ¥¥¥p < 0·001